» Articles » PMID: 25923809

Product Development Studies on Sonocrystallized Curcumin for the Treatment of Gastric Cancer

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2015 Apr 30
PMID 25923809
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Curcumin suffers from the limitation of poor solubility and low dissolution that can lead to limited applications. The investigation was aimed to substantiate the potentiality of melt sonocrystallized gastroretentive tablets of curcumin. Melt sonocrystallized curcumin (MSC CMN) was developed and its therapeutic potential was validated by in vitro cytotoxicity studies against Human oral cancer cell line KB. MSC curcumin was then formulated as floating tablet and evaluated. MSC form of CMN exhibited 2.36-fold and 2.40-fold solubility enhancement in distilled water and phosphate buffer, pH 4.5, respectively, better flow properties and intrinsic dissolution rate (0.242 ± 1.42 and 0.195 ± 1.26 mg/cm2/min) in comparison to its original form. The GI50 value of MSC CMN was found to be less than 10, specifying inhibition of growth more effectively at its least concentration by 50%. The gastroretentive-floating tablet (Formulation F4) displayed controlled drug release (96.22% ± 1.43%) for over 12 h. The present study revealed melt sonocrystallization can be used to produce particles with superior biopharmaceutical properties without the use of organic solvents or the addition of other excipients, and amenable to formulation in to a pharmaceutical dosage form.

Citing Articles

Polymeric Excipients in the Technology of Floating Drug Delivery Systems.

Blynskaya E, Tishkov S, Vinogradov V, Alekseev K, Marakhova A, Vetcher A Pharmaceutics. 2022; 14(12).

PMID: 36559272 PMC: 9786229. DOI: 10.3390/pharmaceutics14122779.


Physicochemical investigation of a novel curcumin diethyl γ-aminobutyrate, a carbamate ester prodrug of curcumin with enhanced anti-neuroinflammatory activity.

Jithavech P, Suwattananuruk P, Hasriadi , Muangnoi C, Thitikornpong W, Towiwat P PLoS One. 2022; 17(3):e0265689.

PMID: 35303012 PMC: 9048745. DOI: 10.1371/journal.pone.0265689.


Use of nanosystems to improve the anticancer effects of curcumin.

Araya-Sibaja A, Salazar-Lopez N, Wilhelm Romero K, Vega-Baudrit J, Dominguez-Avila J, Velazquez Contreras C Beilstein J Nanotechnol. 2021; 12:1047-1062.

PMID: 34621615 PMC: 8450944. DOI: 10.3762/bjnano.12.78.


Preparation and Characterization of Instant Casein Phosphopeptide by Supercritical Fluid Assisted Atomization.

Zhu J, Liu H, Cai X, Wu W, Zhu Z, Yu L Foods. 2021; 10(7).

PMID: 34359425 PMC: 8304231. DOI: 10.3390/foods10071555.

References
1.
Jagtap V, Vidyasagar G, Dvivedi S . Solubility enhancement of rosiglitazone by using melt sonocrystallization technique. J Ultrasound. 2014; 17(1):27-32. PMC: 3945191. DOI: 10.1007/s40477-014-0074-9. View

2.
Kumar A, Ahuja A, Ali J, Baboota S . Curcumin loaded nano globules for solubility enhancement: preparation, characterization and ex vivo release study. J Nanosci Nanotechnol. 2013; 12(11):8293-302. DOI: 10.1166/jnn.2012.6620. View

3.
Dhumal R, Biradar S, Yamamura S, Paradkar A, York P . Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability. Eur J Pharm Biopharm. 2008; 70(1):109-15. DOI: 10.1016/j.ejpb.2008.04.001. View

4.
Abbaraju P, Meka A, Jambhrunkar S, Zhang J, Xu C, Popat A . Floating tablets from mesoporous silica nanoparticles. J Mater Chem B. 2020; 2(47):8298-8302. DOI: 10.1039/c4tb01337a. View

5.
Arya P, Pathak K . Assessing the viability of microsponges as gastro retentive drug delivery system of curcumin: optimization and pharmacokinetics. Int J Pharm. 2013; 460(1-2):1-12. DOI: 10.1016/j.ijpharm.2013.10.045. View